Lindbrook Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$127K Buy
1,734
+1,603
+1,224% +$132K 0.01% 576
2024
Q4
$10.8K Sell
131
-6
-4% -$473 ﹤0.01% 1617
2024
Q3
$9.8K Buy
137
+1
+0.7% +$71 ﹤0.01% 1689
2024
Q2
$9.31K Buy
136
+127
+1,411% +$7.59K ﹤0.01% 1664
2024
Q1
$483 Hold
9
﹤0.01% 2523
2023
Q4
$480 Sell
9
-30
-77% -$1.46K ﹤0.01% 2584
2023
Q3
$1.94K Buy
39
+29
+290% +$1.62K ﹤0.01% 2142
2023
Q2
$595 Sell
10
-1
-9% -$57 ﹤0.01% 2472
2023
Q1
$623 Sell
11
-140
-93% -$8.98K ﹤0.01% 2565
2022
Q4
$11.2K Buy
151
+9
+6% +$613 ﹤0.01% 1383
2022
Q3
$8K Buy
142
+117
+468% +$7.05K ﹤0.01% 1422
2022
Q2
$1K Sell
25
-259
-91% -$17K ﹤0.01% 2247
2022
Q1
$21K Buy
284
+259
+1,036% +$18K ﹤0.01% 982
2021
Q4
$2K Sell
25
-100
-80% -$7.26K ﹤0.01% 1779
2021
Q3
$10K Sell
125
-20
-14% -$1.61K ﹤0.01% 987
2021
Q2
$11K Buy
145
+20
+16% +$1.42K ﹤0.01% 1009
2021
Q1
$8K Hold
125
﹤0.01% 1096
2020
Q4
$8K Hold
125
﹤0.01% 990
2020
Q3
$6K Hold
125
﹤0.01% 1026
2020
Q2
$6K Buy
+125
New +$6.03K ﹤0.01% 1013

Other funds holding GMED

Lindbrook Capital's GMED Position: Q1 2025 in Review

Lindbrook Capital increased its Globus Medical (GMED) stake by 1,224% in Q1 2025, buying an estimated $132K and bringing the position to 1,734 shares worth $127K. The position accounts for 0.01% of the portfolio, ranked #576.

Lindbrook Capital first reported a position in GMED in Q2 2020 and has held it in 20 quarters since. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Lindbrook Capital held 1,734 shares of Globus Medical worth $127K as of Q1 2025.
  • Lindbrook Capital bought 1,603 Globus Medical shares in Q1 2025, an estimated $132K.
  • Globus Medical made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #576 holding.
  • Lindbrook Capital first reported a position in Globus Medical in Q2 2020 and has held it in 20 quarters since.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.